Grants and Contributions:

Title:

Neuromuscular junction-on-a-chip for rapid diagnosis of neuromuscular diseases and applications in precision medicine

Agreement Number:

997002

Agreement Value:

$699,000.00

Agreement Date:

Sep 26, 2022 - Mar 14, 2024

Description:

Neuromuscular diseases (NMDs) affect approximately 13 million worldwide, there is no cure and no effective therapy. There is a major need for robust, scalable, and reproducible in vitro models of human neuromuscular junctions (NMJ) to test therapeutic candidates. Ananda Devices, guided by the needs from the top pharmaceutical company in this market, developed a first-in-class, patent protected technology that enables the establishment of a highly standardized human NMJ in vitro. In this project, we scale up this platform with high reproducibility and quality.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Montreal, Quebec, CA H4R 3E9

Reference Number:

172-2022-2023-Q3-997002

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

799217898

Recipient Type:

For-profit organization

Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days.

Amendment Date

Nov 30, 2023

Recipient's Operating Name:

ANANDA Devices

Recipient's Legal Name:

Ananda Devices Inc.

Federal Riding Name:

Saint-Laurent

Federal Riding Number:

24068

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

54199

Amendments:

See Amendments